British drugmaker AstraZeneca started testing an antibody-based cocktail for the prevention and treatment of Covid-19, adding to recent signs of progress on possible medical solutions to the disease caused by the novel coronavirus.
Johnson & Johnson aims to test the company’s experimental coronavirus vaccine in up to 60,000 volunteers in a late-stage trial scheduled to start in September, according to a U.S. government database of clinical trials.
The U.S. Department of Health and Human Services (HHS) said McKesson Corp. will be the central distributor for future coronavirus vaccines, sending the U.S. drug distributor’s shares up more than 3%.
(Reuters) – Any potential COVID-19 vaccine backed by the Trump administration’s “Operation Warp Speed” program is unlikely to receive a green light from regulators any earlier than November or December, given the time needed for a large-scale clinical trial, the National Institutes of Health director said on Thursday. In a call with reporters, Francis Collins […]
California reported a record increase of more than 11,800 new cases of Covid-19, according to a Reuters tally of county data, as the Trump administration pushes for schools to reopen to help businesses return to normal.
Drugmakers partnered with the U.S. government are on track to begin actively manufacturing a vaccine for COVID-19 by the end of the summer, a senior administration official said.
Florida reported a record increase of more than 15,000 new cases of COVID-19 in 24 hours on Sunday, as the Trump administration renewed a push for schools to reopen and anti-mask protests were planned in Michigan and Missouri.
The United States reported more than 55,000 new COVID-19 casesy, a new daily global record for the coronavirus pandemic, as infections rose in a majority of states.
U.S. National Institutes of Health Director Dr. Francis Collins said he was optimistic that the Trump administration’s vaccine-acceleration program “Operation Warp Speed” will generate a safe and effective vaccine for COVID-19 by year end.
The U.S. Supreme Court ruled that a 2003 law does not violate constitutional free speech rights by requiring overseas affiliates of American-based nonprofit groups that seek federal funding for HIV/AIDS relief to take a formal stance opposing prostitution and sex trafficking.